Skip to main content Back to Top
Advertisement

9/8/2016

Fomepizole Injection

Products Affected - Description

    • Fomepizole injection, Sandoz, 1 gram/mL, 1.5 mL vial, 1 count, NDC 00781-3182-73
    • Fomepizole injection, Sandoz, 1 gram/mL, 1.5 mL vial, 5 count, NDC 00781-3182-84

Reason for the Shortage

    • Sandoz discontinued fomepizole injection.[1]
    • X-Gen has fomepizole injection available.[3]
    • Mylan Institutional has fomepizole injection available.[4]

Available Products

    • Fomepizole injection, Mylan Institutional, 1 gram/mL, 1.5 mL vial, 1 count, NDC 67457-0211-02
    • Fomepizole injection, X-Gen, 1 gram/mL, 1.5 mL vial, 1 count, NDC 39822-0710-01

Estimated Resupply Dates

    • All marketed presentations are available.[3,4]

Implications for Patient Care

    • Fomepizole is an antidote labeled to treat known or suspected ethylene glycol or methanol intoxication. Fomepizole may be used alone or in combination with hemodialysis.[2,5,6]

Safety

    • Fomepizole therapy alone does not replace the need for supportive fluid and electrolyte therapy to address metabolic acidosis.[5,6]

Alternative Agents & Management

    • Consult a poison center (1-800-222-1222) or medical toxicologist for any patient with a suspected ethylene glycol or methanol intoxication.
    • Ethanol is an alternative to fomepizole. Oral ethanol may be preferred to an extemporaneous intravenous preparation due to potential delays in preparation.[6] Commercial intravenous ethanol in dextrose solutions are no longer marketed.[6]
    • Consultation with a poison center or medical toxicologist is essential when using ethanol as an antidote. Ethanol must be dosed according to patient specific criteria such as past tolerance and requires significant laboratory monitoring.[6]

References

    1. Sandoz (personal communications). March 10 and 30, April 27, September 8, and October 28, 2015; February 22, April 15, and September 7, 2016.
    2. Fomepizole injection [product information]. Princeton, NJ: Sandoz; 2010.
    3. X-Gen (personal communications). March 11 and 30, April 27, May 18 and 29, June 29, September 8, October 28, November 9 and 19, 2015; January 12, February 22, March 1, April 15, June 9, and September 8, 2016.
    4. Mylan Institutional (personal communications). March 11 and 30, April 27, May 4 and 18, June 29, September 8, October 28, 2015; January 15, February 22, April 15, June 9, and September 8, 2016.
    5. McEvoy GK, Snow EK, Kester L, Litvak K, Miller J, Welsh OH, eds. AHFS DI (Lexi-Comp Online). Bethesda, MD: American Society of Health-System Pharmacists; 2015.
    6. Antidotes in Depth - Ethanol. In: Hoffman RS, Howland MA, Lewin NA, Nelson, LS, and Goldfrank LR, eds. Goldfrank's Toxicologic Emergencies, 10th ed. New York, NY: McGraw Hill Education; 2015:1369-1372.

Updated

Updated September 8, 2016 by Elyse MacDonald, PharmD, MS, BCPS. Created May 29, 2015 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.

ADVERTISEMENT